EverSource Wealth Advisors’s AngioDynamics ANGO Stock Holding History

EverSource Wealth Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.49K	Sell	131 -158	-55%	-$1.71K	﹤0.01%	3739
2025 Q4	$3.71K	Buy	289 +52	+22%	+$642	﹤0.01%	3236
2025 Q3	$2.65K	Sell	237 -134	-36%	-$1.29K	﹤0.01%	3418
2025 Q2	$3.68K	Buy	371 +252	+212%	+$2.47K	﹤0.01%	3287
2025 Q1	$1.12K	Sell	119 -8	-6%	-$84	﹤0.01%	3190
2024 Q4	$1.16K	Buy	+127	New	+$934	﹤0.01%	2914
2022 Q4	–	Sell	-46	Closed	-$1K	–	2307
2022 Q3	$1K	Buy	+46	New	+$1.01K	﹤0.01%	1772
2022 Q1	–	Sell	-83	Closed	-$2K	–	1700
2021 Q4	$2K	Buy	+83	New	+$2.29K	﹤0.01%	1501

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

EverSource Wealth Advisors's ANGO Position: Q1 2026 in Review

EverSource Wealth Advisors reduced its AngioDynamics (ANGO) stake by 55% in Q1 2026, selling an estimated $1.71K and leaving 131 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3739.

EverSource Wealth Advisors first reported a position in ANGO in Q4 2021 and has held it in 8 quarters since. The position peaked at $3.71K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

EverSource Wealth Advisors held 131 shares of AngioDynamics worth $1.49K as of Q1 2026.
EverSource Wealth Advisors sold 158 AngioDynamics shares in Q1 2026, an estimated $1.71K.
AngioDynamics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3739 holding.
EverSource Wealth Advisors first reported a position in AngioDynamics in Q4 2021 and has held it in 8 quarters since.
EverSource Wealth Advisors's AngioDynamics position peaked at $3.71K in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.